Highest-materiality recent filing
Stryker Q1 net sales $6.0B up 2.6%; adjusted EPS down 8.5% to $2.60; maintains FY guidance
Net sales $6.0B (+2.6% reported, +2.4% organic); MedSurg/Neuro +5.0%, Orthopaedics +0.1%.
Incident identified March 11, 2026; caused business disruptions.
Stryker updates cyber incident: contained, no customer data accessed per Unit 42
Threat actor used malicious file to hide activity; file not capable of spreading internally or externally.
Stryker updates on cyber incident: operations disrupted, patient services unaffected
Cybersecurity incident affecting Microsoft environment disclosed March 11; CISO provided update March 12.
Stryker reports global cybersecurity incident affecting Microsoft systems; investigation ongoing
Incident detected March 11, 2026; global disruption to Microsoft environment; no ransomware or malware; contained.
Stryker reports Q4 2025 sales $7.2B, +11% organic; 2026 outlook 8-9.5% organic growth
Q4 reported EPS $2.20 (+56% YoY); adjusted EPS $4.47 (+11.5%).
Stryker Q3 net sales +10.3% to $6.1B; raises FY 2025 guidance
Reported EPS $2.22 (+2.8%); adjusted EPS $3.19 (+11.1%).
Stryker Q2 2025: net sales $6.0B +11.1%, adj EPS $3.13 +11.4%, raises FY guidance
Net sales $6.0B +11.1% reported (+10.2% organic); MedSurg/Neuro +17.3%, Orthopaedics +2.0% (ex-spinal +10.7%).
Emily Baculik, who currently serves as Vice President, Corporate Controller, will also serve as chief accounting officer of the Company effective September 1, 2026
William E. Berry, Jr. has decided to retire from his role as Vice President, Chief Accounting Officer of the Company effective September 1, 2026
Max materiality 0.85 · Median 0.70 · Most common event earnings